Some of the world's largest medical device companies have swapped CEOs in the last couple of years, which may have had a hand in slowing merger and acquisition activity to a 3-year low.
Medical device mergers & acquisition activity is as scarce in 2012 as during the global financial meltdown in 2009, perhaps because of a concurrent flurry of CEO turnovers.
medtech companies have announced $20 billion worth of deals so far for 2012, less than half of the $53.32 billion worth posted in 2011, according to a Thomson Reuters report.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Covidien lands 510(k) clearance for its iDrive Ultra Powered surgical stapling system, which the company calls the only fully powered, battery operated and reusable endoscopic stapler available worldwide.
Covidien (NYSE:COV) touted FDA clearance for its iDrive Ultra Powered surgical stapler, which the company calls the only fully powered, reusable, battery-operated endoscopic surgical stapler in the world.
The iDrive Ultra is the 2nd in Covidien's line of powered stapling devices and the 1st to fit all of the device maker's Endo GIA staple reloads, according to a press release.
Covidien discontinues the Duet TRS surgical staples that it recalled earlier this year following reports of patients injuries and deaths.
Covidien (NYSE:COV) discontinued certain Duet TRS single-use surgical stapling systems following reports of patients deaths and injuries.
The medical device company cut the Duet TRS Universal Straight and Articulating Single-Use Loading Units following a single report linking the tissue reinforcement devices to a post-operative injury, according to a press release.
Covidien announces the 2nd recall in as many months after at least 4 patients were burned by grounding pads contained in some tumor ablation kits.
Covidien (NYSE:COV) announced a new recall, its 2nd in as many months, after receiving reports of serious burn injuries associated with certain grounding pads contained in ablation device kits.
Covidien's Nellcor patient monitoring subsidiary wants a judge to stop CAS Medical Systems from protesting the validity of a patent with the U.S. Patent & Trademark Office.
Medical device giant Covidien recalls certain tracheostomy tubes following reports of leakage or disconnection during patient ventilation.
Covidien (NYSE:COV) recalled certain lots of its cuffed Shiley tracheostomy tubes after receiving reports that the devices malfunctioned during patient ventilation.
The recall received Class I status from the FDA, designating a device issue "in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death."